Antibiotic Discovery Hurdles: Could Data Sharing, Research Hub Solve Problem?
This article was originally published in The Pink Sheet Daily
Executive Summary
With input from industry, Pew Charitable Trusts proposes formation of entity dedicated to basic research; first step is finding someone to fund the estimated $200m cost for five-year initiative.
You may also be interested in...
Cempra's Solithromycin On Track To Enter Generic, But Resistant, CABP Market
FDA schedules November advisory committee for Cempra's first-in-class antibiotic for community-acquired bacterial pneumonia.
What Would US FDA Do If Supreme Court Eliminates Or Curtails Chevron Deference?
Lawyers say agency will have to bolster its administrative record as judges tackle complex policy and scientific issues previously left to FDA. Some cases, such as challenges to exclusivity decisions, may be reopened.
What Will FDA Do If Supreme Court Curtails Chevron Deference?
Lawyers say agency will have to bolster its administrative record as judges tackle complex policy and scientific issues previously left to FDA. Some cases, such as challenges to exclusivity decisions, may be reopened.